These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8240458

  • 1. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ, Anlauf M.
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [Abstract] [Full Text] [Related]

  • 2. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW, Welzel D, Burger KJ.
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D, Burger KJ, Weidinger G.
    J Cardiovasc Pharmacol; 1990 May; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [Abstract] [Full Text] [Related]

  • 7. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F, Mariano-Pego G, Viegas J, Correia JM, Botelho MA.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR, Laszt A, Farragi D.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [Abstract] [Full Text] [Related]

  • 14. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM, Correa-Nunes A, Rocha-Gonçalves F, Mariano-Pego G.
    J Cardiovasc Pharmacol; 1992 May; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A, Cristal N.
    J Cardiovasc Pharmacol; 1990 May; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.